Product information

From Health Canada

Current status:

Dormant

Current status date:

2020-01-14

Original market date: See footnote 1

1994-12-31

Product name:

DIOPTICON A LIQ

DIN:

02026465 Electronic product monograph is not available

Company:

PHARMA STULLN INC.
6500 Trans Canada Highway, Suite 400
Pointe-Claire
Quebec
Canada H9R 0A5

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Ophthalmic

Number of active ingredient(s):

2

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

04:04.20  ,  52:32.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

S01GA51 NAPHAZOLINE, COMBINATIONS

Active ingredient group (AIG) number:See footnote5

0213722002

List of active ingredient(s)
Active ingredient(s) Strength
NAPHAZOLINE HYDROCHLORIDE 0.025 %
PHENIRAMINE MALEATE 0.3 %
Version 4.0.2
Date modified: